A. Jacquet

Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and haematology/oncology patients in Switzerland: a multicentre study.

H. Siegrist, A. Jacquet, M. Nepa, 1999, The Journal of antimicrobial chemotherapy.

Complications of BCG vaccine SSI® recent story and risk management plan: the French experience

M. Beyens, F. Cambazard, P. Mismetti, 2013, Pharmacoepidemiology and drug safety.

Local and regional adverse reactions to BCG-SSI vaccination: a 12-month cohort follow-up study.

J. Fagot, P. D'Athis, R. Cohen, 2009, Vaccine.

Campagne nationale de vaccination contre la grippe A (H1N1)v : suivi national de pharmacovigilance

A. Sommet, J. Montastruc, G. Durrieu, 2011 .

[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].

A. Sommet, J. Montastruc, G. Durrieu, 2011, Therapie.

Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009–2010 mass vaccination campaign in France

J. Montastruc, G. Durrieu, A. Castot, 2011, European Journal of Clinical Pharmacology.